BioXcel Therapeutics, Inc. (BTAIQ): Total Assets
$44.92M
As of 2025-12-31
$28.80M
As of 2026-06-30
-39.8%
3-year compound annual growth
-27.2%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $44.92M | +17.2% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $38.34M | -48.0% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $73.70M | -64.2% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $205.85M | -14.0% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $239.44M | +8.9% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $219.94M | +504.4% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $36.39M | -16.4% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $43.55M | n/m | 2020-03-09, Balance as of period end |
| 2017-12-31 | $1.35M | n/a | 2019-03-12, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $44.92M | +17.2% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $2.60M | -28.5% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $12.87M | +43.1% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $4.18M | -52.9% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $30.16M | -54.9% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $131.44M | -35.1% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $5.33M | -60.5% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.67M | -25.3% |
Compare BTAIQ, PMHS, VCNX, ELAB side by side · Screen every company in Pharmaceutical Preparations ↗